Total Funding
32
68
Total FundingSeed raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61392
Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms.
About the Company
Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms. The company focused on delivering transformative improvements in the health and quality of life to individuals affected by the rare genetic disorder neurofibromatosis type 2 (NF2).
Mulberry Biotherapeutics is
based in Wellesley, MA.
Women Founded
